PAVmed (PAVM) Income from Non-Controlling Interests (2018 - 2025)
PAVmed's quarterly Income from Non-Controlling Interests came in at -$1.5 million in Q4 2025, down 416.96% year-on-year from $471360.3 in Q4 2024, and down 137.9% quarter-over-quarter from -$628000.0 in Q3 2025.
PAVmed has reported Income from Non-Controlling Interests for 8 years, with the latest figure at -$1.5 million in Q4 2025.
- For the quarter ending Q4 2025, Income from Non-Controlling Interests fell 416.96% year-over-year to -$1.5 million; the trailing twelve-month figure through Dec 2025 stood at -$2.9 million (up 74.02% YoY), and the FY2025 full-year result was -$2.9 million, up 74.74% from the prior year.
- Income from Non-Controlling Interests for Q4 2025 stood at -$1.5 million, down from -$628000.0 in the prior quarter.
- The five-year high for Income from Non-Controlling Interests was -$289000.0 in Q4 2024, with the low at -$4.3 million in Q1 2023.
- Average Income from Non-Controlling Interests over 5 years is -$2.4 million, with a median of -$2.8 million recorded in 2022.
- Year-over-year, Income from Non-Controlling Interests soared 91.43% in 2024 and slumped 416.96% in 2025.
- Tracing PAVM's Income from Non-Controlling Interests over 5 years: stood at -$2.5 million in 2021, then slumped by 67.09% to -$4.1 million in 2022, then gained by 18.0% to -$3.4 million in 2023, then soared by 91.43% to -$289000.0 in 2024, then tumbled by 416.96% to -$1.5 million in 2025.
- The last three Income from Non-Controlling Interests figures came in at -$1.5 million (Q4 2025), -$628000.0 (Q3 2025), and -$403000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 6.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -2.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -5.85 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 22.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 100,000.00 |
| 10 | PAVmed | 4.15 Mn | -9.02 Mn | -703,000.00 | -1.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1.49 Mn |
| Sep 30, 2025 | -628,000.00 |
| Jun 30, 2025 | -403,000.00 |
| Mar 31, 2025 | -345,000.00 |
| Dec 31, 2024 | -289,000.00 |
| Jun 30, 2024 | -4.09 Mn |
| Mar 31, 2024 | -3.30 Mn |
| Dec 31, 2023 | -3.37 Mn |
| Sep 30, 2023 | -4.08 Mn |
| Jun 30, 2023 | -3.36 Mn |
| Mar 31, 2023 | -4.28 Mn |
| Dec 31, 2022 | -4.11 Mn |
| Sep 30, 2022 | -3.81 Mn |
| Jun 30, 2022 | -3.58 Mn |
| Mar 31, 2022 | -2.76 Mn |
| Dec 31, 2021 | -2.46 Mn |
| Sep 30, 2021 | -1.44 Mn |
| Jun 30, 2021 | -1.20 Mn |
| Mar 31, 2021 | -679,000.00 |
| Dec 31, 2020 | -519,000.00 |
| Sep 30, 2020 | -391,000.00 |
| Jun 30, 2020 | -266,000.00 |
| Mar 31, 2020 | -436,000.00 |
| Dec 31, 2019 | -310,000.00 |
| Sep 30, 2019 | -186,000.00 |
| Jun 30, 2019 | -145,000.00 |
| Mar 31, 2019 | -169,000.00 |
| Dec 31, 2018 | -90,441.00 |
| Sep 30, 2018 | -32,431.00 |
| Jun 30, 2018 | -81,200.00 |